Cardiomyopathy|https://phgkb.cdc.gov/GAPPKB/phgHome.do|Cardiomyopathy

https://phgkb.cdc.gov/GAPPKB/phgHome.do

From Guideline Database

This database contains updated guidelines, policies and recommendations on genomic research and practice, as provided by professional organizations, federal advisory groups, expert panels and policy groups.

---

• Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.  
  Published 2015 (American Heart Association) (American College of Cardiology)
• Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.  
  Published 2015 (American Heart Association) (American College of Cardiology)
• 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).  
  Published 2014 (Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology)

more